Infinity Pharmaceuticals Chief Medical Officer Robert Ilaria receives $1.2M in 2021
Infinity Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
Infinity Pharmaceuticals reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, three executives at Infinity Pharmaceuticals received on average a compensation package of $1.2M, a 42% decrease compared to previous year.
Average pay of disclosed executives at Infinity Pharmaceuticals
Robert Ilaria, Jr., Chief Medical Officer, received $1.2M in total. 71% of Ilaria's compensation, or $879K, was in option awards. Ilaria also received $150K in bonus, $56K in non-equity incentive plan, $144K in salary, as well as $9.6K in other compensation.
Adelene Q. Perkins, Chief Executive Officer, received a compensation package of $1.1M, which decreased by 58% compared to previous year. 60% of the compensation package, or $690K, was in salary.
Stephane Peluso, Chief Scientific Officer, earned $1.1M in 2021.
Related executives
You may also like
Source: SEC filing on April 25, 2022.